Newborn screening for severe combined immunodeficiency in Israel

International Journal of Neonatal Screening

Volumn 3, Issue 2, 2017, Pages

  Rechavi, Erez ^a   Lev, Atar ^a   Saraf Levy, Talia ^b   Etzioni, Amos ^c   Almashanu, Shlomo ^b   Somech, Raz ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

ARTEMIS; DNA cross link repair protein 1c (DCLRE1C); Israel; Newborn screening (NBS); Severe combined immunodeficiency (SCID); T cell receptor excision circle (TREC)

Indexed keywords

EID: 85034047543     PISSN: None     EISSN: 2409515X     Source Type: Journal    
DOI: 10.3390/ijns3020013     Document Type: Review

References (33)

1. The Central Bureau of Statistics (Israel). Available online: http://www.cbs.gov.il/reader/?MIval=cw_usr_view_SHTML&ID=638 (accessed on 18 April 2017).
2. Na’amnih, W.; Romano-Zelekha, O.; Kabaha, A.; Rubin, L.P.; Bilenko, N.; Jaber, I.; Honovich, M.; Shohat, T. Continuous decrease of consanguineous marriages among arabs in Israel. Am. J. Hum. Biol. 2015, 27, 94–98. [CrossRef] [PubMed]
3. Zlotogora, J.; Leventhal, A.; Amitai, Y. The impact of congenital malformations and mendelian diseases on infant mortality in Israel. Isr. Med. Assoc. J. 2003, 5, 416–418. [PubMed]
4. Golan, H.; Dalal, I.; Garty, B.Z.; Schlesinger, Levy, J.; Handzel, Z.; Wolach, B.; Rottem, M.; Goldberg, A.; Tamir, R.; et al. The incidence of primary immunodeficiency syndromes in Israel. Isr. Med. Assoc. J. 2002, 4, 868–871. [PubMed]
5. Broides, A.; Nahum, A.; Mandola, A.B.; Rozner, L.; Pinsk, V.; Ling, G.; Yerushalmi, B.; Levy, J.; Givon-Lavi, N. Incidence of typically severe primary immunodeficiency diseases in consanguineous and non-consanguineous populations. J. Clin. Immunol. 2017, 37, 295–300. [PubMed]
6. Ministry of Health (Israel). Available online: http://www.health.gov.il/hozer/bz19_2015.pdf (accessed on 14 April 2017).
7. Almashanu, S.; Sela, B.A.; Zlotogora, J. The national program for neonatal screening. Isr. J. Pediatr. 2008, 65, 6–9.
8. Dvorak, C.C.; Cowan, M.J.; Logan, B.R.; Notarangelo, L.D.; Griffith, L.M.; Puck, J.M.; Kohn, D.B.; Shearer, W.T.; O’Reilly, R.J.; Fleishe, T.A.; et al. The natural history of children with severe combined immunodeficiency: Baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J. Clin. Immunol. 2014, 33, 1156–1164. [CrossRef] [PubMed]
9. Kwan, A.; Abraham, R.S.; Currier, R.; Brower, A.; Andruszewski, K.; Abbott, J.K.; Baker, M.; Ballow, M.; Bartoshesky, L.E.; Bonagura, V.R.; et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014, 312, 729–738. [CrossRef] [PubMed]
10. Brown, L.; Xu-Bayford, J.; Allwood, Z.; Slatter, M.; Cant, A.; Davies, E.G.; Veys, P.; Gennery, A.R.; Gaspar, H.B. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: The case for newborn screening brief report neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome. Blood 2011, 117, 3243–3246. [CrossRef] [PubMed]
11. Baker, M.W.; Laessig, R.H.; Katcher, M.L.; Routes, J.M.; Grossman, W.J.; Verbsky, J.; Kurtycz, D.F.; Brokopp, C.D. Implementing routine testing for severe combined immunodeficiency within wisconsin’s newborn screening program. Public Health Rep. 2010, 125, 88–95. [PubMed]
12. Lev, A.; Simon, A.J.; Trakhtenbrot, L.; Goldstein, I.; Nagar, M.; Stepensky, P.; Rechavi, G.; Amariglio, N.; Somech1, R. Characterizing T cells in SCID patients presenting with reactive or residual T lymphocytes. Clin. Dev. Immunol. 2012, 2012, 9. [CrossRef] [PubMed]
13. Somech, R.; Simon, A.J.; MSc, A.L.; Dalal, I.; Spirer, Z.; Goldstein, I.; Nagar, M.; Amariglio, N.; Rechavi, G. Reduced central tolerance in omenn syndrome leads to immature self-reactive oligoclonal T cells. J. Allergy Clin. Immunol. 2009, 124, 793–800. [CrossRef] [PubMed]
14. Amariglio, N.; Lev, A.; Simon, A.; Rosenthal, E.; Spirer, Z.; Efrati, O.; Broides, A.; Rechavi, G.; Somech, R. Molecular assessment of thymus capabilities in the evaluation of T-cell immunodeficiency. Pediatr. Res. 2010, 67, 211–216. [CrossRef] [PubMed]
15. Kraus, M.; Lev, A.; Simon, A.J.; Levran, I.; Nissenkorn, A.; Levi, Y.B.; Berkun, Y.; Efrati, O.; Amariglio, N.; Rechavi, G.; Somech, R. Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia. J. Clin. Immunol. 2014, 34, 561–572. [CrossRef] [PubMed]
16. Dar, N.; Gothelf, D.; Korn, D.; Frisch, A.; Weizman, A.; Michaelovsky, E.; Carmel, M.; Yeshayahu, Y.; Dubnov-Raz, G.; Pessach, I.M.; et al. Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome. Pediatr. Res. 2015, 77, 579–585. [CrossRef] [PubMed]
17. Lev, A.; Simon, A.J.; Bareket, M.; Bielorai, B.; Hutt, D.; Amariglio, N.; Rechavi, G.; Somech, R. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients. PLoS ONE 2012, 7, e30494. [CrossRef] [PubMed]
18. Amariglio, N.; Klein, A.; Dagan, L.; Lev, A.; Padeh, S.; Rechavi, G.; Berkun, Y.; Somech, R. T-cell compartment in synovial fluid of pediatric patients with JIA correlates with disease phenotype. J. Clin. Immunol. 2011, 31, 1021–1028. [CrossRef] [PubMed]
19. Rechavi, E.; Lev, A.; Lee, Y.N.; Simon, A.J.; Yinon, Y.; Lipitz, S.; Amariglio, N.; Weisz, B.; Notarangelo, L.D.; Somech, R. Timely and spatially regulated maturation of B and T cell repertoire during human fetal development. Sci. Transl. Med. 2015, 7, 1–12. [CrossRef] [PubMed]
20. Somech, R.; Lev, A.; Simon, A.J.; Korn, D.; Garty, B.Z.; Amariglio, N.; Rechavi, G.; Almashanu, S.; Zlotogora, J.; Etzioni, A. Newborn screening for severe T and B cell immunodeficiency in Israel: A pilot study. Isr. Med. Assoc. J. 2013, 15, 404–409. [PubMed]
21. Somech, R.; Etzioni, A. A call to include severe combined immunodeficiency in newborn screening program. Rambam Maimonides Med. J. 2014, 5, e0001. [CrossRef] [PubMed]
22. Van Der Spek, J.; Groenwold, R.H.H.; Van Der Burg, M.; Van Montfrans, J.M. TREC based newborn screening for severe combined immunodeficiency disease: A systematic review. J. Clin. Immunol. 2015, 35, 416–430. [CrossRef] [PubMed]
23. PerkinElmer Enlite Neonatal TREC Kit. Available online: https://newbornscreening.perkinelmer.com/files/358/EnLite_Neonatal_TREC_BRO_(ROW)_1599-9774-01_.pdf (accessed on 24 May 2017).
24. Barbaro, M.; Ohlsson, A.; Borte, S.; Jonsson, S.; Zetterström, R.H.; King, J.; Winiarski, J.; Döbeln, U.V.; Hammarström, L. Newborn screening for severe primary immunodeficiency diseases in sweden—A 2-year pilot TREC and KREC screening study. J. Clin. Immunol. 2016, 37, 1–10. [CrossRef] [PubMed]
25. Dalal, I.; Tasher, D.; Somech, R.; Etzioni, A.; Garti, B.Z.; Lev, D.; Cohen, S.; Somekh, E.; Leshinsky-Silver, E. Novel mutations in RAG1/2 and ADA genes in israeli patients presenting with T-B-SCID or omenn syndrome. Clin. Immunol. 2011, 140, 284–290. [CrossRef] [PubMed]
26. Moshous, D.; Callebaut, I.; de Chasseval, R.; Corneo, B.; Cavazzana-Calvo, M.; Le Deist, F.; Tezcan, I.; Sanal, O.; Bertrand, Y.; Philippe, N.; et al. ARTEMIS, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001, 105, 177–186. [CrossRef]
27. Felgentreff, K.; Lee, Y.N.; Frugoni, F.; Du, L.; van der Burg, M.; Giliani, S.; Tezcan, I.; Reisli, I.; Mejstříková, E.; de Villartay, J.P.; et al. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency. J. Allergy Clin. Immunol. 2015, 136, 140–150. [CrossRef] [PubMed]
28. Kwan, A.; Puck, J.M. History and current status of newborn screening for severe combined immunodeficiency. Semin. Perinatol. 2015, 39, 194–205. [CrossRef] [PubMed]
29. Li, L.; Moshous, D.; Zhou, Y.; Wang, J.; Xie, G.; Salido, E.; Hu, D.; de Villartay, J.P.; Cowan, M.J. A founder mutation in ARTEMIS, an SNM1-Like protein, causes SCID in athabascan-speaking native americans. J. Immunol. 2002, 168, 6323–6329. [CrossRef] [PubMed]
30. Borte, S.; von Döbeln, U.; Fasth, A.; Wang, N.; Janzi, M.; Winiarski, J.; Sack, U.; Pan-Hammarström, Q.; Borte, M.; Hammarström, L. Brief report neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012, 119, 1–4. [CrossRef] [PubMed]
31. Kwan, A.; Church, J.A.; Cowan, M.J.; Agarwal, R.; Kapoor, N.; Kohn, D.B.; Lewis, D.B.; McGhee, S.A.; Moore, T.B.; Stiehm, E.R.; et al. Newborn screening for SCID and T Cell lymphopenia in california: Results of the first two years. J. Allergy Clin. Immunol. 2013, 132, 140–150. [CrossRef] [PubMed]
32. Roifman, C.M.; Somech, R.; Kavadas, F.; Pires, L.; Nahum, A.; Dalal, I.; Grunebaum, E. Defining combined immunodeficiency. J. Allergy Clin. Immunol. 2012, 130, 177–183. [CrossRef] [PubMed]
33. Lev, A.; Simon, A.J.; Broides, A.; Levi, J.; Garty, B.Z.; Rosenthal, E.; Amariglio, N.; Rechavi, G.; Somech, R. Thymic function in MHC class II-deficient patients. J. Allergy Clin. Immunol. 2013, 131, 831–839. [CrossRef] [PubMed]